7Baggers
 indaptus therapeutics reports q3 2025 financial results and corporate update  Quiver Quantitative Wed, 12 Nov 2025 13:44:00 GMT
 Indaptus Therapeutics Q3 profit beats estimates  TradingView Wed, 12 Nov 2025 13:38:25 GMT

Indaptus Therapeutics, Inc.
(NASDAQ:INDP) 

INDP stock logo

Indaptus Therapeutics, Inc., a pre-clinical stage biotech company, develops a patented anti-cancer and antiviral immunotherapy. It engages in developing a pre-clinical pipeline of therapeutic candidates intended to elicit anti-tumor and anti-viral responses, as well as cure diseases. The company's l...

CEO: Jeffrey A. Meckler  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends